Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.
Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.
Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.
By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.
The Ensign Group director reports a new stock grant. Director Daren Shaw received an award of 600 shares of Ensign Group common stock on January 15, 2026 at a price of $0 per share. Following this award, he beneficially owns 24,726 common shares directly.
The grant is subject to a multi-year vesting schedule. The 600 shares vest in three equal annual installments beginning January 15, 2027, meaning one-third of the award becomes fully owned each year over three years.
The Ensign Group director reports a new stock award. Director Ann Scott Blouin acquired 600 shares of Ensign Group common stock on January 15, 2026 in a transaction reported at a price of $0 per share, indicating a share grant rather than a market purchase. After this award, she beneficially owns 23,227 Ensign Group shares in direct ownership.
The filing notes that these 600 shares vest in three equal annual installments beginning January 15, 2027, so the director will earn the shares over time rather than receiving them all at once.
The Ensign Group director Abbott Swati Bargotra reported receiving 600 shares of common stock of The Ensign Group, Inc. on January 15, 2026 in a Form 4 filing. The shares were acquired at a stated price of $0 per share, indicating they were granted as equity compensation rather than purchased on the market. Following this award, Bargotra beneficially owns 19,632 shares of Ensign common stock in total. According to the footnote, these 600 shares vest in three equal annual installments beginning on January 15, 2027, meaning the director earns the shares over time, subject to the vesting schedule.
The Ensign Group director receives stock grant
Director John O. Agwunobi reported an award of 600 shares of Ensign Group common stock on January 15, 2026, at a stated price of $0 per share, indicating a stock-based compensation grant rather than an open-market purchase. After this grant, he beneficially owns 9,479.149 shares directly.
The footnote explains that these 600 shares are subject to a vesting schedule, vesting in three equal annual installments beginning January 15, 2027, which spreads the compensation over time and ties it to continued service.
The Ensign Group director reports new stock award. Director Mark Vincent Parkinson reported receiving 600 shares of The Ensign Group, Inc. common stock on January 15, 2026, recorded at a price of $0 per share, indicating an equity grant rather than a market purchase. After this award, he beneficially owns 3,000 shares of common stock in total.
The 600-share award is structured to vest over time, with the shares vesting in three equal annual installments beginning on January 15, 2027. This staged vesting schedule ties the director’s equity compensation to continued service with the company.
A shareholder has filed a Rule 144 notice for a planned sale of 246 shares of common stock, to be executed through Fidelity Brokerage Services LLC on the NASDAQ. The filing lists an aggregate market value of 44,235.72 for these shares and states that the approximate sale date is 01/20/2026.
The 246 shares to be sold were acquired via restricted stock vesting from the issuer as compensation, with 100 shares vesting on 01/15/2026 and 146 shares on 01/16/2026. The notice also references a prior sale by the same person of 246 common shares on 11/06/2025 for gross proceeds of 46,462.02.
The Ensign Group, Inc. reported an insider stock transaction by its VP and Chief Legal Officer. On December 12, 2025, the officer exercised 2,500 employee stock options at an exercise price of $44.84 per share, acquiring the same number of common shares.
On the same date, the officer sold 1,000, 5,846 and 1,554 shares of common stock at weighted average sale prices of $174.1075, $175.516 and $176.207, respectively, leaving 32,779 common shares owned directly after the transactions and no remaining derivative securities. The activity was effected under a Rule 10b5-1 trading plan adopted on September 2, 2025, using options originally granted on May 28, 2020 that vest over five equal annual installments.
The Ensign Group, Inc. (ENSG) officer, the President and COO, reported an option exercise and share sale. On 11/20/2025, he exercised 3,690 employee stock options at an exercise price of $15.93 per share, receiving the same number of common shares. On the same date, he sold 3,690 common shares at a price of $180 per share. After these transactions, he beneficially owned 51,165 shares of Ensign common stock in direct ownership form.
The filing states that the transaction was carried out under a Rule 10b5-1 trading plan adopted on August 14, 2025. The options exercised were originally granted on August 31, 2016 and vested in five equal annual installments.
Ensign Group, Inc. (ENSG) President and COO filed a Form 4 reporting multiple stock transactions in November 2025. On 11/17/2025, the officer made a gift of 4,229 shares of common stock and exercised stock options for 5,899 shares at $16.60 per share, then sold 5,899 shares at $177.30 per share. On 11/18/2025, the officer exercised options for 2,209 shares at $15.93 per share and sold 2,209 shares at $180.00 per share. After these transactions, the officer directly owned 51,165 shares of Ensign Group common stock and held 3,690 employee stock options. The filing notes that the transactions were carried out under a Rule 10b5-1 trading plan adopted on August 14, 2025.
Ensign Group, Inc. director reports small stock sale under 10b5-1 plan. A company director filed a Form 4 disclosing the sale of 1,000 shares of Ensign Group, Inc. common stock at a price of $178.57 per share on 11/18/2025. The transaction was coded as a sale and executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on May 7, 2025. After this trade, the director beneficially owns 24,126 shares of Ensign Group, Inc., all held directly.